First human tests begin for new experimental injection
NCT ID NCT06494527
Summary
This is an early-stage study to check the safety and basic effects of a new injection called RG002C0106 in healthy adults. Researchers will give different doses to small groups of volunteers and compare them to a placebo (dummy shot) to see how the body handles it and if it causes any side effects. The main goal is to gather initial safety information before testing in people with specific diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY ISSUES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, 101125, China
Conditions
Explore the condition pages connected to this study.